Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-09 Sale | 2024-09-11 4:00 pm | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 20,000 | $9.5 | $190,000 | 101,957 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Option Award | 2024-01-25 4:02 pm | N/A 2034-01-23 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 110,000 | $3.06 | 110,000 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:03 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 6:15 pm | N/A 2029-02-12 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 1,858 | $0 | 175,673 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 6:15 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 1,858 | $3.72 | 175,673 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:10 pm | N/A 2028-01-30 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 4,392 | $0 | 175,673 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:10 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 675 | $0.73 | 175,673 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:10 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 3,717 | $3.72 | 175,673 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:27 pm | N/A 2032-01-25 | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2022-01-11 4:03 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer | 0 | $0 | 320,267 (Direct) | View |
Ownership | 2020-11-13 5:52 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. See Remarks | 0 | $0 | 270,267 (Direct) | View |